BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 36043665)

  • 1. Use of artificial intelligence in ophthalmology: a narrative review.
    Martins TGDS; Schor P; Mendes LGA; Fowler S; Silva R
    Sao Paulo Med J; 2022; 140(6):837-845. PubMed ID: 36043665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insights into the growing popularity of artificial intelligence in ophthalmology.
    Dutt S; Sivaraman A; Savoy F; Rajalakshmi R
    Indian J Ophthalmol; 2020 Jul; 68(7):1339-1346. PubMed ID: 32587159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Artificial Intelligence (AI) Applications for Age-Related Macular Degeneration (AMD) and Other Retinal Dystrophies.
    Perepelkina T; Fulton AB
    Semin Ophthalmol; 2021 May; 36(4):304-309. PubMed ID: 33764255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Artificial intelligence in ophthalmology.
    Popescu Patoni SI; Muşat AAM; Patoni C; Popescu MN; Munteanu M; Costache IB; Pîrvulescu RA; Mușat O
    Rom J Ophthalmol; 2023; 67(3):207-213. PubMed ID: 37876505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COVID 19 repercussions in ophthalmology: a narrative review.
    Dos Santos Martins TG; Dos Santos Martins DG; Dos Santos Martins TG; Marinho P; Schor P
    Sao Paulo Med J; 2021; 139(5):535-542. PubMed ID: 34378743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Artificial intelligence: the unstoppable revolution in ophthalmology.
    Benet D; Pellicer-Valero OJ
    Surv Ophthalmol; 2022; 67(1):252-270. PubMed ID: 33741420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ethics of Artificial Intelligence in Medicine and Ophthalmology.
    Abdullah YI; Schuman JS; Shabsigh R; Caplan A; Al-Aswad LA
    Asia Pac J Ophthalmol (Phila); 2021 May-Jun 01; 10(3):289-298. PubMed ID: 34383720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An overview of artificial intelligence in diabetic retinopathy and other ocular diseases.
    Sheng B; Chen X; Li T; Ma T; Yang Y; Bi L; Zhang X
    Front Public Health; 2022; 10():971943. PubMed ID: 36388304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Artificial Intelligence in Ophthalmology - Status Quo and Future Perspectives.
    Wawer Matos PA; Reimer RP; Rokohl AC; Caldeira L; Heindl LM; Große Hokamp N
    Semin Ophthalmol; 2023 Apr; 38(3):226-237. PubMed ID: 36356300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent evidence of economic evaluation of artificial intelligence in ophthalmology.
    Ruamviboonsuk P; Ruamviboonsuk V; Tiwari R
    Curr Opin Ophthalmol; 2023 Sep; 34(5):449-458. PubMed ID: 37459289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Everything real about unreal artificial intelligence in diabetic retinopathy and in ocular pathologies.
    Morya AK; Janti SS; Sisodiya P; Tejaswini A; Prasad R; Mali KR; Gurnani B
    World J Diabetes; 2022 Oct; 13(10):822-834. PubMed ID: 36311999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Artificial intelligence in glaucoma.
    Nair M; Tagare S; Venkatesh R; Odayappan A
    Indian J Ophthalmol; 2022 May; 70(5):1868-1869. PubMed ID: 35502116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The upcoming role of Artificial Intelligence (AI) for retinal and glaucomatous diseases.
    Ferro Desideri L; Rutigliani C; Corazza P; Nastasi A; Roda M; Nicolo M; Traverso CE; Vagge A
    J Optom; 2022; 15 Suppl 1(Suppl 1):S50-S57. PubMed ID: 36216736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Digital technology, tele-medicine and artificial intelligence in ophthalmology: A global perspective.
    Li JO; Liu H; Ting DSJ; Jeon S; Chan RVP; Kim JE; Sim DA; Thomas PBM; Lin H; Chen Y; Sakomoto T; Loewenstein A; Lam DSC; Pasquale LR; Wong TY; Lam LA; Ting DSW
    Prog Retin Eye Res; 2021 May; 82():100900. PubMed ID: 32898686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of Artificial Intelligence in Targeting Retinal Diseases.
    Sorrentino FS; Jurman G; De Nadai K; Campa C; Furlanello C; Parmeggiani F
    Curr Drug Targets; 2020; 21(12):1208-1215. PubMed ID: 32640954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Artificial intelligence for telemedicine diabetic retinopathy screening: a review.
    Nakayama LF; Zago Ribeiro L; Novaes F; Miyawaki IA; Miyawaki AE; de Oliveira JAE; Oliveira T; Malerbi FK; Regatieri CVS; Celi LA; Silva PS
    Ann Med; 2023; 55(2):2258149. PubMed ID: 37734417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The era of artificial intelligence-based individualized telemedicine is coming.
    Jheng YC; Kao CL; Yarmishyn AA; Chou YB; Hsu CC; Lin TC; Hu HK; Ho TK; Chen PY; Kao ZK; Chen SJ; Hwang DK
    J Chin Med Assoc; 2020 Nov; 83(11):981-983. PubMed ID: 32568967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [ARTIFICIAL INTELLIGENCE IN OPHTHALMOLOGY].
    Erdinest N; Ben Ephraim Noyman D; Lavy I; Berkow D; Pincovich S; London N; Shmueli O; Levinger N; Morad Y; Landau D; Levi Vineberg T
    Harefuah; 2024 Jan; 163(1):37-42. PubMed ID: 38297419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advancements and turning point of artificial intelligence in ophthalmology: A comprehensive analysis of research trends and collaborative networks.
    Ahn J; Choi M
    Ophthalmic Physiol Opt; 2024 Jul; 44(5):1031-1040. PubMed ID: 38581209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The current state of artificial intelligence in ophthalmology.
    Kapoor R; Walters SP; Al-Aswad LA
    Surv Ophthalmol; 2019; 64(2):233-240. PubMed ID: 30248307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.